» Articles » PMID: 17322172

An Essential Role for Gp130 in Neointima Formation Following Arterial Injury

Overview
Journal Circ Res
Date 2007 Feb 27
PMID 17322172
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin (IL)-6 induced vascular smooth muscle cell (VSMC) motility in a dose-dependent manner. In addition, IL-6 stimulated tyrosine phosphorylation of gp130, resulting in the recruitment and activation of STAT-3. IL-6-induced VSMC motility was found to be dependent on activation of gp130/STAT-3 signaling. IL-6 also induced cyclin D1 expression in a time- and gp130/STAT-3-dependent manner in VSMCs. Suppression of cyclin D1 levels via the use of its small interfering RNA molecules inhibited IL-6-induced VSMC motility. Furthermore, balloon injury induced IL-6 expression both at mRNA and protein levels in rat carotid artery. Balloon injury also caused increased STAT-3 phosphorylation and cyclin D1 expression, leading to smooth muscle cell migration from the media to the intimal region. Blockade of gp130/STAT-3 signaling via adenovirus-mediated expression of dngp130 or dnSTAT-3 attenuated balloon injury-induced STAT-3 phosphorylation and cyclin D1 induction, resulting in reduced smooth muscle cell migration from media to intima and decreased neointima formation. Together, these observations for the first time suggest that IL-6/gp130/STAT-3 signaling plays an important role in vascular wall remodeling particularly in the settings of postangioplasty and thereby in neointima formation.

Citing Articles

Vascular smooth muscle cells enhance immune/vascular interplay in a 3-cell model of vascular inflammation.

Wiejak J, Murphy F, Maffia P, Yarwood S Sci Rep. 2023; 13(1):15889.

PMID: 37741880 PMC: 10517978. DOI: 10.1038/s41598-023-43221-8.


Deletion of Smooth Muscle Lethal Giant Larvae 1 Promotes Neointimal Hyperplasia in Mice.

Zhang Y, Yuan P, Ma X, Deng Q, Gao J, Yang J Front Pharmacol. 2022; 13:834296.

PMID: 35140622 PMC: 8819082. DOI: 10.3389/fphar.2022.834296.


Sinomenine in Cardio-Cerebrovascular Diseases: Potential Therapeutic Effects and Pharmacological Evidences.

Zhang M, Wang X, Shi J, Yu J Front Cardiovasc Med. 2021; 8:749113.

PMID: 34660748 PMC: 8517137. DOI: 10.3389/fcvm.2021.749113.


Transforming growth factor β1 suppresses proinflammatory gene program independent of its regulation on vascular smooth muscle differentiation and autophagy.

Gao P, Wu W, Ye J, Lu Y, Adam A, Singer H Cell Signal. 2018; 50:160-170.

PMID: 30006123 PMC: 6389266. DOI: 10.1016/j.cellsig.2018.07.002.


An Interleukin-6 Receptor Antibody Suppresses Atherosclerosis in Atherogenic Mice.

Akita K, Isoda K, Sato-Okabayashi Y, Kadoguchi T, Kitamura K, Ohtomo F Front Cardiovasc Med. 2018; 4:84.

PMID: 29312959 PMC: 5743912. DOI: 10.3389/fcvm.2017.00084.